Literature DB >> 1936607

Evolution of insulin resistance in New Zealand obese mice.

M C Veroni1, J Proietto, R G Larkins.   

Abstract

The etiology of non-insulin-dependent diabetes mellitus (NIDDM) is not known. Hyperglycemia is due to increased hepatic glucose production (HGP), decreased glucose uptake, and impaired insulin secretion. It is unknown if these defects are coinherited or if one precedes and causes the others. The aim of this study was to determine the earliest defects in the evolution of the syndrome in the New Zealand obese (NZO) mouse, a polygenic model of NIDDM. NZO and control NZC mice were studied at 4-5 and 20 wk of age. Glucose turnover and glucose uptake in individual tissues were measured basally and during a hyperinsulinemic clamp. First-phase insulin secretion was measured after an intravenous glucose load. HGP was higher in the NZO mice both basally and during the clamp at both ages. At 4-5 wk of age, there was evidence of insulin insensitivity in brown adipose tissue, soleus, diaphragm, red quadriceps, and red gastrocnemius but not in heart, white quadriceps, and white gastrocnemius. In 20-wk-old mice, insulin responsiveness was decreased in white and brown adipose tissue and soleus muscle but not in heart, diaphragm, red and white quadriceps, and red and white gastrocnemius. First-phase insulin secretion (percentage rise above basal) 3 min after the glucose bolus was impaired in NZO mice at both ages. We conclude that hepatic glucose overproduction, brown adipose tissue and skeletal muscle insulin resistance, and impaired first-phase insulin secretion are all early abnormalities in the NZO mouse.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1936607     DOI: 10.2337/diab.40.11.1480

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  16 in total

1.  Establishment of "The Gene Mine": a resource for rapid identification of complex trait genes.

Authors:  Grant Morahan; Lois Balmer; Donald Monley
Journal:  Mamm Genome       Date:  2008-08-21       Impact factor: 2.957

Review 2.  Metabolic and therapeutic lessons from genetic manipulation of GLUT4.

Authors:  M J Charron; E B Katz
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

3.  The biochemical basis of increased hepatic glucose production in a mouse model of type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  S Andrikopoulos; J Proietto
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

4.  Altered upper airway and soft tissue structures in the New Zealand Obese mouse.

Authors:  Michael J Brennick; Allan I Pack; Kei Ko; Eugene Kim; Stephen Pickup; Greg Maislin; Richard J Schwab
Journal:  Am J Respir Crit Care Med       Date:  2008-11-07       Impact factor: 21.405

5.  Increased nicotinamide nucleotide transhydrogenase levels predispose to insulin hypersecretion in a mouse strain susceptible to diabetes.

Authors:  K Aston-Mourney; N Wong; M Kebede; S Zraika; L Balmer; J M McMahon; B C Fam; J Favaloro; J Proietto; G Morahan; S Andrikopoulos
Journal:  Diabetologia       Date:  2007-10-06       Impact factor: 10.122

6.  Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones.

Authors:  Andrew W Norris; Lihong Chen; Simon J Fisher; Ildiko Szanto; Michael Ristow; Alison C Jozsi; Michael F Hirshman; Evan D Rosen; Laurie J Goodyear; Frank J Gonzalez; Bruce M Spiegelman; C Ronald Kahn
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

Review 7.  Animal models of obesity and diabetes mellitus.

Authors:  Maximilian Kleinert; Christoffer Clemmensen; Susanna M Hofmann; Mary C Moore; Simone Renner; Stephen C Woods; Peter Huypens; Johannes Beckers; Martin Hrabe de Angelis; Annette Schürmann; Mostafa Bakhti; Martin Klingenspor; Mark Heiman; Alan D Cherrington; Michael Ristow; Heiko Lickert; Eckhard Wolf; Peter J Havel; Timo D Müller; Matthias H Tschöp
Journal:  Nat Rev Endocrinol       Date:  2018-01-19       Impact factor: 43.330

8.  The role of liver fructose-1,6-bisphosphatase in regulating appetite and adiposity.

Authors:  Sherley Visinoni; Nurul Fathiah Izzati Khalid; Christos N Joannides; Arthur Shulkes; Mildred Yim; Jon Whitehead; Tony Tiganis; Benjamin J Lamont; Jenny M Favaloro; Joseph Proietto; Sofianos Andrikopoulos; Barbara C Fam
Journal:  Diabetes       Date:  2012-05       Impact factor: 9.461

9.  Lost in translation.

Authors:  David H Wasserman; Julio E Ayala; Owen P McGuinness
Journal:  Diabetes       Date:  2009-09       Impact factor: 9.461

Review 10.  Genetically modified mouse models to help fight COVID-19.

Authors:  Channabasavaiah B Gurumurthy; Rolen M Quadros; Guy P Richardson; Larisa Y Poluektova; Suzanne L Mansour; Masato Ohtsuka
Journal:  Nat Protoc       Date:  2020-10-26       Impact factor: 13.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.